↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

477 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   1 mg/kg cnto 136   -   -   -   -   1件:
49 
 2   10 mg/kg cnto 136   -   -   -   -   1件:
49 
 3   2-deoxy-2 [f-18] fluoro-2-d-glucose   D-glucose   D00009   -   -   1件:
49 
 4   4 mg/kg cnto 136   -   -   -   -   1件:
49 
 5   81mg aspirin   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
49 
 6   A-623   -   -   -   -   1件:
49 
 7   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 8   Abbv-105   -   -   -   -   2件:
46,
49 
 9   Abetimus   Abetimus   -   -   -   1件:
49 
 10   Abetimus sodium   Abetimus   -   -   -   1件:
49 
 11   Abetimus sodium (ljp 394)   Abetimus   -   -   -   1件:
49 
 12   Abr-215757   -   -   -   -   2件:
49,
51 
 13   Abt-199   -   -   -   -   1件:
49 
 14   Ac0058ta   -   -   -   -   1件:
49 
 15   Acetaminophen   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   11件:
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271 
 16   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 17   Acetylcysteine   Acetylcysteine   D00221   -   -   14件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 18   Acido micofenolico   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
49 
 19   Act-334441   -   -   -   -   1件:
49 
 20   Acthar   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   6件:
2,
13,
46,
49,
50,
222 
 21   Acthar gel   -   -   -   -   4件:
13,
46,
49,
84 
 22   Acthar high dose (80 u)   -   -   -   -   1件:
49 
 23   Acthar low dose (40 u)   -   -   -   -   1件:
49 
 24   Ags-009   -   -   -   -   1件:
49 
 25   Aidsvax® b/e   -   -   -   -   1件:
49 
 26   Akbm-3031   -   -   -   -   1件:
49 
 27   Aldesleukin   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   3件:
49,
65,
97 
 28   Alfacalcidol   Alfacalcidol   D01518   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   6件:
41,
46,
49,
50,
96,
235 
 29   Alitretinoin   Alitretinoin   D02815   5件: RARA, RARB, RXRA, RXRB, RXRG   17件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease (NAFLD), Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer   1件:
49 
 30   Allogeneic mesenchymal stromal cells derived from the umbilical cord   -   -   -   -   1件:
49 
 31   Allogeneic msc (allomsc)   -   -   -   -   1件:
49 
 32   Allogeneic stem cell transplantation   -   -   -   -   2件:
49,
84 
 33   Alpha-tocopherol   Tocopherol   D02332   -   -   1件:
49 
 34   Alx-0061   -   -   -   -   2件:
46,
49 
 35   Amg 557   -   -   -   -   1件:
49 
 36   Amg 570   -   -   -   -   2件:
46,
49 
 37   Amg 592   -   -   -   -   2件:
46,
49 
 38   Amg 623   -   -   -   -   1件:
49 
 39   Amg 811   -   -   -   -   1件:
49 
 40   Amg811   -   -   -   -   1件:
49 
 41   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 42   Anifrolumab   Anifrolumab   D11082   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   2件:
46,
49 
 43   Anifrolumab 1000 mg   Anifrolumab   D11082   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
49 
 44   Anifrolumab 300 mg   Anifrolumab   D11082   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
49 
 45   Anti-cd19-car-t cells   -   -   -   -   1件:
49 
 46   Anti-cd20 b cell depletion with truxima   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
49 
 47   Anti-macrophage migration inhibitory factor (anti-mif) antibody   -   -   -   -   1件:
49 
 48   Anti-pandemic h1n1 influenza vaccine   -   -   -   -   5件:
46,
49,
50,
51,
53 
 49   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 50   Asf-1096 cream 0.25%   -   -   -   -   1件:
49 
 51   Asf-1096 cream 0.5%   -   -   -   -   1件:
49 
 52   Asf-1096 cream 1.0%   -   -   -   -   1件:
49 
 53   Aspirin   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231 
 54   Aspirin and meloxicam   Meloxicam   D00969   1件: PTGS2   20件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
49 
 55   Atacicept   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
49,
66 
 56   Atacicept 150 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 57   Atacicept 75 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 58   Atacicept 75 milligram (mg)   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 59   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 60   Autologous ebv specific ctl infusion   -   -   -   -   1件:
49 
 61   Aviptadil   Aviptadil   -   -   -   4件:
49,
51,
85,
86 
 62   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 63   Baricitinib   Baricitinib   D10308   2件: JAK1, JAK2   32件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   8件:
41,
46,
49,
50,
93,
107,
265,
325 
 64   Belimumab   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   8件:
11,
43,
44,
46,
49,
51,
53,
222 
 65   Belimumab 1 mg/kg   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
46,
49 
 66   Belimumab 10 mg/kg   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
43,
46,
49 
 67   Belimumab 10 mg/kg plus standard therapy   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 68   Belimumab 100 mg sc   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 69   Belimumab 10mg/kg   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 70   Belimumab 200 mg sc   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 71   Belimumab 200 mg/ml   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 72   Belimumab 4 mg/kg   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
46,
49 
 73   Belimumab for iv   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 74   Belimumab for sc   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 75   Belimumab injection   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 76   Belimumab or benlysta   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 77   Belimumab plus early vaccination   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 78   Belimumab plus late vaccination   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 79   Benlysta   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 80   Benlysta (belimumab)   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
11,
49,
53,
222 
 81   Benlysta 400 mg powder for concentrate for solution for infusion   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 82   Benlysta™ (belimumab)   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 83   Bi 705564   -   -   -   -   1件:
49 
 84   Biib059   -   -   -   -   1件:
49 
 85   Blisibimod   Blisibimod   D10311   -   -   5件:
43,
44,
49,
63,
66 
 86   Blood sample   -   -   -   -   12件:
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 87   Bms-188667   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   6件:
46,
49,
65,
96,
97,
271 
 88   Bms-931699   Lulizumab pegol   -   -   -   2件:
49,
53 
 89   Bms-986165   -   -   -   -   3件:
49,
96,
97 
 90   Bms-986165 capsule   -   -   -   -   1件:
49 
 91   Bms-986165 tablet   -   -   -   -   1件:
49 
 92   Bortezomib   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 93   Bos161721   -   -   -   -   1件:
49 
 94   Br-dim   -   -   -   -   1件:
49 
 95   Brentuximab vedotin   Brentuximab vedotin   D09587   10件: TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   4件: Cytokine-cytokine receptor interaction, Gap junction, Pathogenic Escherichia coli infection, Phagosome   2件:
49,
51 
 96   Bt063   -   -   -   -   1件:
49 
 97   Busulfan   Busulfan   D00248   -   -   13件:
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326 
 98   Calcitriol   Calcitriol   D00129   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   8件:
37,
46,
49,
66,
96,
158,
235,
326 
 99   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 100   Campath   Alemtuzumab   D02802   -   -   4件:
49,
51,
60,
65 
 101   Cc-220   -   -   -   -   2件:
49,
84 
 102   Cdp3194   -   -   -   -   1件:
49 
 103   Cdp7657   -   -   -   -   1件:
49 
 104   Cellcept   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   3件:
11,
42,
49 
 105   Cenerimod   Cenerimod   D11283   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
49 
 106   Cenerimod 0.5 mg   Cenerimod   D11283   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
49 
 107   Cenerimod 1 mg   Cenerimod   D11283   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
49 
 108   Cenerimod 2 mg   Cenerimod   D11283   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
49 
 109   Cenerimod 4 mg   Cenerimod   D11283   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
49 
 110   Cep-33457   -   -   -   -   1件:
49 
 111   Cfz533   -   -   -   -   4件:
11,
46,
49,
53 
 112   Chloroquine   Chloroquine   D02125, D02366, D03469   -   -   4件:
46,
49,
95,
130 
 113   Cholecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   9件:
13,
19,
34,
46,
49,
96,
97,
298,
299 
 114   Cholecalciferol and c. xanthorrhiza   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
49 
 115   Ciclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   13件:
26,
46,
49,
50,
53,
55,
60,
61,
97,
222,
226,
228,
269 
 116   Ciclosporina   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   2件:
49,
228 
 117   Clofarabine   Clofarabine   D03546   3件: POLA1, POLA2, RRM1   6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   9件:
19,
20,
40,
46,
49,
60,
96,
234,
326 
 118   Clopidogrel   Clopidogrel   D00769, D07729, D10823, D10824   1件: P2RY12   1件: Platelet activation   2件:
49,
86 
 119   Conjugated equine estrogens   Conjugated estrogens   D04070, D05987   -   -   1件:
49 
 120   Conjugated equine estrogens 0.625 mg/d + mpa 5 mg/d/10d   Conjugated estrogens   D04070, D05987   -   -   1件:
49 
 121   Continuation of azathioprine   Azathioprine   D00238, D03033   -   -   1件:
49 
 122   Corticosteroids   -   -   -   -   9件:
41,
46,
49,
64,
97,
164,
220,
296,
300 
 123   Corticosteroids (prednisone or prednisolone)   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
49 
 124   Creatine   Creatine   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 125   Crestor   Rosuvastatin   D01915, D08492   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   3件:
49,
79,
299 
 126   Csm allogéniques issues de cordons ombilicaux ( mti-pp)   Afamelanotide   D10511   -   -   1件:
49 
 127   Ctla4-igg4m (rg2077)   -   -   -   -   1件:
49 
 128   Ctla4ig   -   -   -   -   4件:
46,
49,
96,
271 
 129   Cumulative corticosteroid exposure   -   -   -   -   1件:
49 
 130   Curcumin   Curcumin   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299 
 131   Curcumin supplement   Curcumin   -   -   -   1件:
49 
 132   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 133   Cyclophosphamide-prednisone-azathioprine   Cyclophosphamide   D00287, D07760   -   -   1件:
49 
 134   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 135   Cyclosporin a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   11件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
113,
164 
 136   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 137   Cyclosporine a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   8件:
19,
20,
36,
49,
53,
58,
60,
234 
 138   Cymbalta   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
49 
 139   Cytarabine   Cytarabine   D00168, D03046, D03637   -   -   6件:
11,
13,
14,
25,
49,
60 
 140   D-glucose   D-glucose   D00009   -   -   3件:
49,
86,
88 
 141   Dapagliflozin   Dapagliflozin   D08897   -   -   2件:
49,
222 
 142   Dapirolizumab pegol   -   -   -   -   1件:
49 
 143   Dapirolizumab pegol (dzp)   -   -   -   -   1件:
49 
 144   Dehydroepiandrosterone   Prasterone   D08409   3件: AR, ESR1, ESR2   11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway   5件:
49,
53,
83,
96,
113 
 145   Dehydroepiandrosterone (dhea)   Prasterone   D08409   3件: AR, ESR1, ESR2   11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
49 
 146   Dhea   Prasterone   D08409   3件: AR, ESR1, ESR2   11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway   3件:
49,
86,
96 
 147   Dihydroartemisinin   Artenimol   D07362   -   -   1件:
49 
 148   Dihydroartemisinin tablet   Artenimol   D07362   -   -   1件:
49 
 149   Dimethylfumarat   -   -   -   -   1件:
49 
 150   Diphenhydramine   Diphenhydramine   D00300, D00669, D02419, D03285, D03360, D03854   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   5件:
49,
51,
70,
86,
256 
 151   Dipyridamole   Dipyridamole   D00302   2件: PDE4A, PDE5A   6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
46,
49,
51,
66,
224 
 152   Docosahexaenoic acid   Doconexent   -   -   -   7件:
6,
49,
90,
94,
240,
299,
301 
 153   Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom   -   -   -   -   2件:
46,
49 
 154   Edratide   Edratide   D03957   -   -   1件:
49 
 155   Eicosapentaenoic acid   Icosapent   D08061   -   -   5件:
49,
96,
97,
296,
297 
 156   Epa and dha supplementation   -   -   -   -   2件:
48,
49 
 157   Epratuzumab   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 158   Epratuzumab 100 mg   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 159   Epratuzumab 1200 mg   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 160   Epratuzumab 400 mg   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 161   Epratuzumab 600 mg   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 162   Epratuzumab iv   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 163   Epratuzumab sc   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 164   Erl080a   -   -   -   -   1件:
49 
 165   Estradiol   Estradiol   D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   5件:
13,
46,
49,
226,
299 
 166   Ethinyl estradiol   Estradiol   D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   3件:
46,
49,
299 
 167   Ethylhydrogenfumarat, calciumsalz   -   -   -   -   1件:
49 
 168   Ethylhydrogenfumarat, magnesiumsalz   -   -   -   -   1件:
49 
 169   Ethylhydrogenfumarat, zinksalz   -   -   -   -   1件:
49 
 170   Evobrutinib   Evobrutinib   -   -   -   3件:
13,
46,
49 
 171   Extended release dipyridamole 200mg/aspirin 25mg   Dipyridamole   D00302   2件: PDE4A, PDE5A   6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
49 
 172   Ezetimibe   Ezetimibe   D01966   1件: NPC1L1   1件: Fat digestion and absorption   4件:
49,
79,
93,
260 
 173   Ezetimibe+simvastatin drug combination   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
49 
 174   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 175   Fish oil   Fish oil   -   -   -   7件:
13,
46,
49,
66,
96,
260,
299 
 176   Fludarabine   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 177   Fludarabine monophosphate   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   4件:
49,
65,
284,
326 
 178   Fludarabine phosphate   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   11件:
28,
36,
49,
51,
60,
62,
65,
96,
283,
284,
285 
 179   Fluorine f 18   -   -   -   -   4件:
40,
46,
49,
96 
 180   Fluzone   -   -   -   -   1件:
49 
 181   Focetria (monovalent mf59-adjuvanted vaccine)   -   -   -   -   3件:
46,
49,
271 
 182   Folate   Folic acid   D00070   -   -   3件:
13,
46,
49 
 183   Folatescan (technetium tc 99mec20)   -   -   -   -   4件:
13,
46,
49,
96 
 184   Folic acid   Folic acid   D00070   -   -   4件:
6,
46,
49,
84 
 185   Forigerimod   Forigerimod   D09904   -   -   1件:
49 
 186   Fostamatinib   Fostamatinib   D09347   1件: SYK   15件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   4件:
46,
49,
61,
66 
 187   Fostamatinib disodium (r935788)   Fostamatinib   D09347   1件: SYK   15件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   2件:
46,
49 
 188   Fumaderm   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
49 
 189   Fumaderm®   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
49 
 190   Fumaderm® initial   Dimethyl fumarate   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
49 
 191   G-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   12件:
6,
13,
16,
49,
51,
60,
65,
85,
96,
284,
285,
331 
 192   Gardasil   Human papillomavirus type 6 l1 capsid protein antigen   -   -   -   1件:
49 
 193   Gc+hcq   -   -   -   -   1件:
49 
 194   Gdc-0853   -   -   -   -   2件:
46,
49 
 195   Gdc-0853 (high dose)   -   -   -   -   1件:
49 
 196   Gdc-0853 (low dose)   -   -   -   -   1件:
49 
 197   Gdc-0853 ro7010939   -   -   -   -   2件:
46,
49 
 198   Gl701   -   -   -   -   1件:
49 
 199   Group a sle prospective study   -   -   -   -   1件:
49 
 200   Growth colony stimulating factor (g-csf)   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
49 
 201   Gsk1550188   -   -   -   -   3件:
11,
49,
222 
 202   Gsk1550188 1mg/kg or 10mg/kg   -   -   -   -   1件:
49 
 203   Gsk1550188 iv   -   -   -   -   1件:
49 
 204   Gsk1550188 sc   -   -   -   -   1件:
49 
 205   Gsk2586184   -   -   -   -   1件:
49 
 206   Gsk2586184 100 mg   -   -   -   -   1件:
49 
 207   Gsk2586184 200 mg   -   -   -   -   1件:
49 
 208   Gsk2586184 400 mg   -   -   -   -   1件:
49 
 209   Gsk2586184 50 mg   -   -   -   -   1件:
49 
 210   Gsk2586184 800mg single and repeat dose   -   -   -   -   1件:
49 
 211   Gsk2586184 new formulation   -   -   -   -   1件:
49 
 212   Gsk2586184 standard formulation   -   -   -   -   1件:
49 
 213   H.p. acthar gel   -   -   -   -   5件:
46,
49,
50,
84,
222 
 214   Hematopoietic stem cell transplantation   -   -   -   -   12件:
11,
13,
14,
19,
20,
35,
46,
49,
51,
96,
234,
285 
 215   Hgs1006   -   -   -   -   1件:
49 
 216   Hgs1006, lymphostat-b, monoclonal anti-blys, lsb, benlysta   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
49,
53 
 217   High dietary sodium   -   -   -   -   1件:
49 
 218   High dose mesenchymal stem cells (mscs)   -   -   -   -   1件:
49 
 219   Hiomega-3 supplement of naturalis® company -   -   -   -   -   1件:
49 
 220   Hll2   -   -   -   -   1件:
49 
 221   Hll2 (epratuzumab)   Epratuzumab   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49 
 222   Hll2 (trivial name or chemical description)   -   -   -   -   1件:
49 
 223   Hpv prophylactic vaccine gardasil   -   -   -   -   1件:
49 
 224   Hril-2 active   -   -   -   -   3件:
46,
49,
53 
 225   Human papillomavirus vaccination (gardasil)   -   -   -   -   1件:
49 
 226   Human umbilical cord derived msc transplantation for sle   -   -   -   -   1件:
49 
 227   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 228   Hydroxychloroquine (z0188)   Hydroxychloroquine   D08050   -   -   1件:
49 
 229   Hydroxychloroquine high   Hydroxychloroquine   D08050   -   -   1件:
49 
 230   Hydroxychloroquine or chloroquine   Hydroxychloroquine   D08050   -   -   1件:
49 
 231   Hydroxychloroquine reduced   Hydroxychloroquine   D08050   -   -   1件:
49 
 232   Ianalumab   -   -   -   -   3件:
35,
49,
53 
 233   Ibandronate   Ibandronate   D08056   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   2件:
46,
49 
 234   Ibandronate+alfacalcidol+calcium   Alfacalcidol   D01518   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
49 
 235   Ici 182,780 (faslodex)   -   -   -   -   1件:
49 
 236   Icp-022   -   -   -   -   2件:
46,
49 
 237   Ifn-a 2b kinoid drug substance   -   -   -   -   1件:
49 
 238   Ifn-a2b kinoid   -   -   -   -   1件:
49 
 239   Ifn-k   -   -   -   -   2件:
49,
50 
 240   Ifn-kinoid   -   -   -   -   2件:
49,
50 
 241   Ifn-kinoid drug substance   -   -   -   -   2件:
49,
50 
 242   Il-2   Human interleukin-2   -   -   -   5件:
2,
46,
49,
56,
96 
 243   Ilt-101   -   -   -   -   1件:
49 
 244   Immu-103   -   -   -   -   1件:
49 
 245   Immune ablation and hematopoietic stem cell support.   -   -   -   -   1件:
49 
 246   Immunoglobulin g   -   -   -   -   7件:
11,
13,
14,
49,
50,
63,
65 
 247   Immunoglobulin g1, anti-(human type i interferon receptor) (human monoclonal medi-546 heavy chain), disulfide with human monoclonal medi-546-chain, dimer   -   -   -   -   1件:
49 
 248   Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate)   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
49 
 249   Individualized dose of rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
49 
 250   Infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 251   Influenz virus surface antigens   -   -   -   -   1件:
49 
 252   Influenza vaccine (surface antigen, inactivated)   -   -   -   -   1件:
49 
 253   Influvac   -   -   -   -   3件:
46,
49,
50 
 254   Interleukin 2   Human interleukin-2   -   -   -   9件:
46,
49,
51,
56,
63,
95,
96,
97,
271 
 255   Interleukin-2   Human interleukin-2   -   -   -   6件:
2,
35,
49,
55,
65,
97 
 256   Intravenous immunoglobulin   Immune globulin human   -   -   -   16件:
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 257   Ipp-201101   -   -   -   -   1件:
49 
 258   Ipp-201101, p140   -   -   -   -   1件:
49 
 259   Iscalimab   Iscalimab   D11610   1件: CD40   16件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis   1件:
49 
 260   Itolizumab [bmab 600]   -   -   -   -   1件:
49 
 261   Jbt-101   -   -   -   -   4件:
49,
50,
51,
299 
 262   Jnj-55920839   -   -   -   -   1件:
49 
 263   Jnj-56022473   -   -   -   -   1件:
49 
 264   Kineret   Anakinra   D02934   2件: IL1R1, IL1R2   15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer   5件:
41,
49,
65,
266,
299 
 265   Kpg-818   -   -   -   -   1件:
49 
 266   Kzr-616   -   -   -   -   3件:
49,
50,
61 
 267   L04aa26   -   -   -   -   1件:
49 
 268   Laquinimod   Laquinimod   -   -   -   4件:
8,
13,
49,
96 
 269   Leflunomide   Leflunomide   D00749   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   9件:
11,
40,
46,
49,
53,
66,
224,
271,
300 
 270   Lenalidomide   Lenalidomide   D04687   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   7件:
16,
26,
28,
34,
49,
284,
300 
 271   Levothyroxine   Levothyroxine   D01010, D08125   2件: THRA, THRB   2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway   2件:
49,
78 
 272   Ljp 394   -   -   -   -   1件:
49 
 273   Ljp394   -   -   -   -   1件:
49 
 274   Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)   Estradiol   D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   2件:
46,
49 
 275   Low dietary sodium   -   -   -   -   1件:
49 
 276   Low dose mesenchymal stem cells (mscs)   -   -   -   -   1件:
49 
 277   Low-dose aldesleukin (proleukin®)   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   1件:
49 
 278   Lulizumab pegol   Lulizumab pegol   -   -   -   1件:
49 
 279   Lupuzor   -   -   -   -   1件:
49 
 280   Ly2127399   -   -   -   -   3件:
13,
46,
49 
 281   Ly3009104   -   -   -   -   4件:
46,
49,
50,
325 
 282   Ly3361237   -   -   -   -   1件:
49 
 283   Lymphostat-b tm   -   -   -   -   1件:
49 
 284   M2951   -   -   -   -   3件:
13,
46,
49 
 285   M2951 (other name: evobrutinib)   Evobrutinib   -   -   -   1件:
49 
 286   Mabthera (rituximab)   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   4件:
13,
46,
49,
53 
 287   Medi 545   -   -   -   -   1件:
49 
 288   Medi-545   -   -   -   -   2件:
49,
50 
 289   Medi-545 600   -   -   -   -   1件:
49 
 290   Medi-546   -   -   -   -   1件:
49 
 291   Medi-570 0.03 mg   -   -   -   -   1件:
49 
 292   Medi-570 0.1 mg   -   -   -   -   1件:
49 
 293   Medi-570 0.3 mg   -   -   -   -   1件:
49 
 294   Medi-570 1 mg   -   -   -   -   1件:
49 
 295   Medroxyprogesterone   -   -   -   -   1件:
49 
 296   Melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   8件:
6,
13,
46,
49,
90,
97,
144,
202 
 297   Meloxicam   Meloxicam   D00969   1件: PTGS2   20件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   4件:
46,
49,
271,
296 
 298   Memantine   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   7件:
2,
6,
8,
13,
49,
127,
205 
 299   Mesenchymal stem cells   -   -   -   -   11件:
2,
6,
13,
20,
49,
51,
60,
96,
222,
274,
299 
 300   Mesna   Coenzyme m   -   -   -   9件:
13,
44,
45,
49,
51,
60,
65,
96,
164 
 301   Metformin   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   16件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 302   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 303   Methotrexate and folic acid   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   1件:
49 
 304   Methyl prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
43,
49,
96 
 305   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 306   Micofenolico acido   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
49 
 307   Milatuzumab   Milatuzumab   D08944   1件: CD74   3件: Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis   1件:
49 
 308   Milnacipran   Milnacipran   D08222   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
46,
49 
 309   Mizoribine   Mizoribine   D01392   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   7件:
49,
51,
53,
66,
94,
222,
224 
 310   Modafinil   Modafinil   D01832   -   -   4件:
6,
13,
49,
93 
 311   Mofetil   -   -   -   -   1件:
49 
 312   Monitor   Methamidophos   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300 
 313   Moxifloxacin   Moxifloxacin   D00874, D08237   -   -   8件:
2,
6,
46,
49,
85,
86,
240,
299 
 314   Mra 003 us   -   -   -   -   1件:
49 
 315   Msc treatment   -   -   -   -   1件:
49 
 316   Msc2364447c   -   -   -   -   1件:
49 
 317   Mt-1303 high dose   -   -   -   -   1件:
49 
 318   Mt-1303 low dose   -   -   -   -   1件:
49 
 319   Mti   Afamelanotide   D10511   -   -   1件:
49 
 320   Multivitamin   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   1件:
49 
 321   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 322   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 323   Mycophenolate mofetil (mmf)   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   4件:
49,
60,
66,
222 
 324   Mycophenolate motetil   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
49 
 325   Mycophenolic acid   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   7件:
11,
49,
51,
60,
66,
96,
222 
 326   Myfortic   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   4件:
49,
66,
222,
228 
 327   N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide   -   -   -   -   1件:
49 
 328   N-acetylcysteine   Acetylcysteine   D00221   -   -   10件:
6,
13,
19,
20,
49,
58,
85,
111,
164,
299 
 329   Nelfinavir   Nelfinavir   D00899, D08259   -   -   3件:
49,
265,
331 
 330   Nicotinamide   Nicotinamide   D00036   -   -   3件:
6,
49,
162 
 331   Nivolumab   Nivolumab   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97 
 332   Nktr-358   -   -   -   -   1件:
49 
 333   Nnc 0151-0000-0000   -   -   -   -   2件:
46,
49 
 334   Nnc0114-0006   -   -   -   -   2件:
46,
49 
 335   Norethindrone   Norethisterone   D00182, D00953   1件: PGR   4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   4件:
13,
46,
49,
299 
 336   Normal saline   -   -   -   -   14件:
6,
17,
22,
36,
46,
49,
60,
94,
96,
211,
226,
276,
296,
299 
 337   Nox-e36   -   -   -   -   1件:
49 
 338   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 339   Ocrelizumab   Ocrelizumab   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   3件:
13,
46,
49 
 340   Olive   Olea europaea leaf   -   -   -   3件:
13,
49,
53 
 341   Olive oil   Olive oil   D03311   -   -   3件:
13,
49,
53 
 342   Omacor   Omega-3-acid ethyl esters   D05255   2件: CETP, LPL   4件: Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway   1件:
49 
 343   Omega-3   Omega-3 fatty acids   -   -   -   7件:
13,
46,
49,
66,
79,
96,
299 
 344   Oral prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
49,
145 
 345   Oral prednisone 5mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
49 
 346   Ortho-novum 777   -   -   -   -   1件:
49 
 347   Oxygen   Oxygen   D00003   -   -   14件:
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 348   Ozone   Ozone   -   -   -   2件:
49,
51 
 349   Paquinimod   Paquinimod   -   -   -   2件:
49,
51 
 350   Pf-04236921   -   -   -   -   2件:
49,
96 
 351   Pf-06700841   -   -   -   -   3件:
49,
96,
97 
 352   Pf-06700841 15 mg   -   -   -   -   1件:
49 
 353   Pf-06700841 30 mg   -   -   -   -   1件:
49 
 354   Pf-06700841 45 mg   -   -   -   -   1件:
49 
 355   Pf-06835375   -   -   -   -   2件:
46,
49 
 356   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 357   Phosphate-buffered saline   Phosphate ion   -   -   -   1件:
49 
 358   Pioglitazone   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 359   Pitavastatin   Pitavastatin   D01862   -   -   1件:
49 
 360   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 361   Plaquenil   Hydroxychloroquine   D08050   -   -   4件:
46,
49,
53,
96 
 362   Pneumovax   -   -   -   -   3件:
46,
49,
96 
 363   Prasterone   Prasterone   D08409   3件: AR, ESR1, ESR2   11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
49 
 364   Prasterone (gl701)   Prasterone   D08409   3件: AR, ESR1, ESR2   11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
49 
 365   Pravastatin   Pravastatin   D00893, D08410   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   9件:
13,
46,
49,
67,
79,
96,
164,
265,
333 
 366   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 367   Prednisona   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
49,
222 
 368   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 369   Prednisone acetate   Prednisone acetate   D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
40,
49,
224 
 370   Prednisone discontinuation   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
49 
 371   Premarin and provera   -   -   -   -   1件:
49 
 372   Prevenar® and pneumo23®   -   -   -   -   1件:
49 
 373   Proleukin   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   2件:
2,
49 
 374   Quinipril   -   -   -   -   1件:
49 
 375   R-salbutamol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
49 
 376   R-salbutamol sulphate   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
49 
 377   R932333   -   -   -   -   1件:
49 
 378   Rabbit   Rabbit   -   -   -   7件:
13,
49,
51,
60,
65,
96,
285 
 379   Rabbit anti-thymocyte globulin   Rabbit   -   -   -   2件:
49,
65 
 380   Rabbit antithymocyte globulin   Rabbit   -   -   -   3件:
49,
60,
96 
 381   Ramipril   Ramipril   D00421   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   7件:
46,
49,
66,
67,
113,
218,
257 
 382   Rankl/opg ratio   -   -   -   -   1件:
49 
 383   Rapamycin   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   16件:
2,
15,
34,
35,
46,
49,
51,
60,
61,
67,
86,
89,
158,
256,
278,
279 
 384   Raptiva   Efalizumab   D03959   1件: ITGAL   11件: Cell adhesion molecules (CAMs), Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis   3件:
37,
49,
53 
 385   Rayos   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
49 
 386   Rc18 160 mg plus standard therapy   -   -   -   -   1件:
49 
 387   Rc18 240 mg plus standard therapy   -   -   -   -   1件:
49 
 388   Rc18 80 mg plus standard therapy   -   -   -   -   1件:
49 
 389   Remicade   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   8件:
46,
49,
56,
84,
85,
96,
97,
271 
 390   Rhumab 2h7   -   -   -   -   3件:
13,
46,
49 
 391   Rhumab ifnalpha   -   -   -   -   1件:
49 
 392   Riquent   -   -   -   -   1件:
49 
 393   Rituxan (rituximab)   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
49 
 394   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 395   Rivaroxaban   Rivaroxaban   D07086   1件: F10   1件: Complement and coagulation cascades   2件:
46,
49 
 396   Ro 106-1443   -   -   -   -   1件:
49 
 397   Ro 496-4913   -   -   -   -   2件:
46,
49 
 398   Ro7010939/f13   -   -   -   -   1件:
49 
 399   Rontalizumab   Rontalizumab   D09662   13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8   22件: Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis   1件:
49 
 400   Rosuvastatin   Rosuvastatin   D01915, D08492   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   8件:
6,
46,
49,
51,
79,
96,
271,
299 
 401   Rosuvastatin calcium   Rosuvastatin   D01915, D08492   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   3件:
49,
79,
299 
 402   Royal jelly   Royal jelly   D09754   -   -   1件:
49 
 403   Rslv-132   -   -   -   -   2件:
49,
53 
 404   Salbutamol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
3,
11,
49,
85,
86,
228,
256,
299 
 405   Same   Ademetionine   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 406   Sar113244   -   -   -   -   1件:
49 
 407   Sbi-087   -   -   -   -   2件:
46,
49 
 408   Sc belimumab 200 mg   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   1件:
49 
 409   Sifalimumab   Sifalimumab   D09668   13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8   22件: Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis   1件:
49 
 410   Sifalimumab 1,200 mg   Sifalimumab   D09668   13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8   22件: Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis   1件:
49 
 411   Sifalimumab 200 mg   Sifalimumab   D09668   13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8   22件: Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis   1件:
49 
 412   Sifalimumab 600 mg   Sifalimumab   D09668   13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8   22件: Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis   1件:
49 
 413   Simvastatin   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 414   Sm101   -   -   -   -   3件:
49,
63,
66 
 415   Sm934   -   -   -   -   1件:
49 
 416   Sodium-2-mercapto ethane sulphonate   -   -   -   -   1件:
49 
 417   Soluble fc receptor   -   -   -   -   1件:
49 
 418   Soluble fc-gamma receptor iib   -   -   -   -   1件:
49 
 419   Sq fludarabine   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
49 
 420   Standard dose of rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
49 
 421   Standard of care   -   -   -   -   8件:
6,
13,
14,
49,
51,
64,
79,
85 
 422   Standard therapy   -   -   -   -   2件:
49,
97 
 423   Standard therapy (excluding immunosuppressants)   -   -   -   -   1件:
49 
 424   Standard therapy (including immunosuppressants)   -   -   -   -   1件:
49 
 425   Stelara   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   3件:
49,
96,
269 
 426   Steriod taper   -   -   -   -   1件:
49 
 427   Subcuvia   -   -   -   -   3件:
14,
49,
65 
 428   Sugar pill   -   -   -   -   7件:
6,
49,
67,
70,
86,
206,
226 
 429   Sulfamethoxazole   Sulfamethoxazole   D00447   -   -   4件:
44,
49,
85,
299 
 430   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 431   Switch to myfortic   -   -   -   -   1件:
49 
 432   Tab08   -   -   -   -   2件:
46,
49 
 433   Tabalumab   Tabalumab   D10083   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
46,
49 
 434   Tabalumab auto-injector   Tabalumab   D10083   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
46,
49 
 435   Tabalumab prefilled syringe   Tabalumab   D10083   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
46,
49 
 436   Taci-fc5   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
46,
49 
 437   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 438   Tak-079   -   -   -   -   1件:
49 
 439   Thalidomide   Thalidomide   D00754   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 440   The generic name is warfarin and many producers will be involved   Warfarin   D00564, D01280, D08682   2件: NQO1, VKORC1   5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   1件:
49 
 441   Tocopherol   Tocopherol   D02332   -   -   3件:
13,
49,
257 
 442   Tocopherol acetate   Tocopherol   D02332   -   -   1件:
49 
 443   Toctino®   -   -   -   -   1件:
49 
 444   Tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   34件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   9件:
46,
49,
50,
51,
84,
96,
97,
107,
271 
 445   Tofacitinib citrate   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   34件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   3件:
46,
49,
271 
 446   Trade name xarelto   Rivaroxaban   D07086   1件: F10   1件: Complement and coagulation cascades   1件:
49 
 447   Trimethoprim   Trimethoprim   D00145, D06236   -   -   6件:
36,
44,
49,
60,
85,
299 
 448   Trimethoprim-sulfamethoxazole   Sulfamethoxazole   D00447   -   -   2件:
49,
299 
 449   Triptorelin   Triptorelin   D06247   1件: GNRHR   2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction   2件:
49,
76 
 450   Triptorelin pamoate   Triptorelin   D06247   1件: GNRHR   2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction   1件:
49 
 451   Tru-015   -   -   -   -   3件:
46,
49,
222 
 452   Truxima   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
49 
 453   Tv-4710   -   -   -   -   1件:
49 
 454   Upadacitinib   Upadacitinib   D10994   1件: JAK1   26件: EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   6件:
41,
46,
49,
96,
97,
271 
 455   Urine sample   -   -   -   -   3件:
49,
51,
61 
 456   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 457   Ustekinumab (approximately 6 mg/kg)   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   1件:
49 
 458   Ustekinumab 90 milligram (mg)   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   1件:
49 
 459   Ustekinumab iv   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   2件:
49,
97 
 460   Ustekinumab sc   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   2件:
49,
97 
 461   Vaccination   -   -   -   -   1件:
49 
 462   Vaccine   -   -   -   -   1件:
49 
 463   Vay736   -   -   -   -   7件:
13,
35,
46,
49,
53,
85,
95 
 464   Velcade®   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   3件:
11,
46,
49 
 465   Versus hydroxychloroquine   Hydroxychloroquine   D08050   -   -   1件:
49 
 466   Vib7734   -   -   -   -   4件:
49,
50,
51,
53 
 467   Vitamin d   Vitamin d   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 468   Vitamin d 25(oh)d   Vitamin d   -   -   -   1件:
49 
 469   Vitamin d3   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   11件:
6,
13,
20,
46,
49,
53,
60,
65,
96,
97,
299 
 470   Vitamin d3 400 iu   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
49 
 471   Vitamin d3 6000 iu   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
49 
 472   Vitamins: b6, b12, and folate   Folic acid   D00070   -   -   1件:
49 
 473   Warfarin   Warfarin   D00564, D01280, D08682   2件: NQO1, VKORC1   5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   10件:
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 474   Xarelto   Rivaroxaban   D07086   1件: F10   1件: Complement and coagulation cascades   1件:
49 
 475   Xmab5871   -   -   -   -   2件:
49,
300 
 476   Zostavax   -   -   -   -   1件:
49 
 477   Zostavax vaccine   -   -   -   -   2件:
46,
49 

先頭へ